使用帕佐帕尼布探索高血压发展的预测因素,并检查随时间推移的预测性能
Masayuki Kunitake1,2, Aya Goto3, Yoshiro Sakai3
1Department of Pharmacy, Kurume University Hospital, Kurume, Japan; kunitake_masayuki@kurume-u.ac.jp.
确定了帕佐帕尼布诱导的高血压的预测因素. 总 bilirubin 和性别,以及治疗前的缩血压,有助于预测在接受 pazopanib 的患者中高血压的发展.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 心血管医学 心血管医学
背景情况:
- 帕佐帕尼布治疗经常与高血压有关.
- 确定这种不良事件的预测因素对于患者管理至关重要.
研究的目的:
- 为了确定帕佐帕尼布诱导的高血压的预测因素.
- 评估已识别的因素的时间预测性能.
主要方法:
- 对患者背景因素的后勤回归分析.
- 时间依赖的接收器运行特征 (ROC) 分析,以评估随时间推移的预测性能.
- 这项研究包括47名因细胞癌或软组织肉瘤而接受巴佐帕尼布治疗的患者.
主要成果:
- 总胆红素 (T-bil),性别和治疗前的缩血压 (SBP) 被确定为预测因素.
- 时间依赖的ROC分析表明,SBP在早期治疗阶段是一个更强的预测因素,而t-bil在以后更具预测性.
- 组合模型 (SBP+t-bil,SBP+t-bil+sex) 在整个治疗期内显示出持续的预测准确性.
结论:
- 总胆红素和性别是帕佐帕尼布诱导高血压的重要预测因素.
- 从第5天开始,总胆红素显示出预测高血压发展的潜力.
- 这些因素可以帮助早期风险分层和管理pazopanib治疗的患者.
更多相关视频
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
08:12Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
Published on: March 14, 2019
相关概念视频
Factors affecting Blood pressure
Physiological Factors:
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Cancer Survival Analysis
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
